본문 바로가기
KERD
논문KCI 등재

The Korean Version of the University of California San Diego Performance-based Skills Assessment: Reliability and Validity

0

조회

0

다운로드

3

인용

0

참고문헌

키워드

초록

Objective: The study’s aim was to develop and standardize a Korean version of the University of California San Diego Performance-based Skills Assessment (K-UPSA), which is used to evaluate the daily living function of patients with schizophrenia. Methods: Study participants were 78 patients with schizophrenia and 27 demographically matched healthy controls. We evaluated the clinical states and cognitive functions to verify K-UPSA’s reliability and validity. For clinical states, the Positive and Negative Syndrome Scale, Clinical Global Impression-Schizophrenia scale, and Social and Occupational Functioning Assessment Scale and Schizophrenia Quality of Life Scale-fourth revision were used. The Schizophrenia Cognition Rating Scale, Short-form of Korean-Wechsler Adult Intelligence Scale, and Wisconsin Card Sorting Test were used to assess cognitive function. Results: The K-UPSA had statistically significant reliability and validity. The K-UPSA has high internal consistency (Cronbach’s alpha, 0.837) and test-retest reliability (intra-class correlation coefficient, 0.381-0.792; p<0.001). The K-UPSA had significant discriminant validity (p<0.001). Significant correlations between the K-UPSA’s scores and most of the scales and tests listed above demonstrated K-UPSA’s concurrent validity (p<0.001). Conclusion: The K-UPSA is useful to evaluate the daily living function in Korean patients with schizophrenia.

Abstract

Objective: The study’s aim was to develop and standardize a Korean version of the University of California San Diego Performance-based Skills Assessment (K-UPSA), which is used to evaluate the daily living function of patients with schizophrenia. Methods: Study participants were 78 patients with schizophrenia and 27 demographically matched healthy controls. We evaluated the clinical states and cognitive functions to verify K-UPSA’s reliability and validity. For clinical states, the Positive and Negative Syndrome Scale, Clinical Global Impression-Schizophrenia scale, and Social and Occupational Functioning Assessment Scale and Schizophrenia Quality of Life Scale-fourth revision were used. The Schizophrenia Cognition Rating Scale, Short-form of Korean-Wechsler Adult Intelligence Scale, and Wisconsin Card Sorting Test were used to assess cognitive function. Results: The K-UPSA had statistically significant reliability and validity. The K-UPSA has high internal consistency (Cronbach’s alpha, 0.837) and test-retest reliability (intra-class correlation coefficient, 0.381-0.792; p<0.001). The K-UPSA had significant discriminant validity (p<0.001). Significant correlations between the K-UPSA’s scores and most of the scales and tests listed above demonstrated K-UPSA’s concurrent validity (p<0.001). Conclusion: The K-UPSA is useful to evaluate the daily living function in Korean patients with schizophrenia.

참고문헌 (37)

  1. Velligan DI, "The functional significance of symptomatology and cognitive function in schizophrenia", Schizophr Res, 25, pp.21~31 (1997)
  2. Wu EQ, "The economic burden of schizophrenia in the United States in 2002", J Clin Psychiatry, 66, pp.1122~1129 (2005)
  3. 장성만, "Economic Burden of Schizophrenia in South Korea", Journal of Korean Medical Science, 23(2), pp.167~175 (2008), 대한의학회
  4. Korea Employment Agency for the Disabled, "Panoptically 2016 disability statistics" (2016), Korea Employment Agency for the Disabled
  5. Green MF, "Longitudinal studies of cognition and functional outcome in schizophrenia : implications for MATRICS", Schizophr Res, 72, pp.41~51 (2004)
  6. Yoshio Kaneko, "Cognitive Remediation in Schizophrenia", Clinical Psychopharmacology and Neuroscience, 10(3), pp.125~135 (2012), 대한정신약물학회
  7. Evans JD, "The relationship of neuropsychological abilities to specific domains of functional capacity in older schizophrenia patients", Biol Psychiatry, 53, pp.422~430 (2003)
  8. Malla AK, "Symptoms, cognition, treatment adherence and functional outcome in first-episode psychosis", Psychol Med, 32, pp.1109~1119 (2002)
  9. Bell MD, "Work rehabilitation in schizophrenia:does cognitive impairment limit improvement?", Schizophr Bull, 27, pp.269~279 (2001)
  10. American Psychiatric Association DSM Task Force, "Diagnostic and Statistical Manual of Mental Disorders" (2013), American Psychiatric Association
  11. Patterson TL, "UCSD Performance-Based Skills Assessment : development of a new measure of everyday functioning for severely mentally ill adults", Schizophr Bull, 27, pp.235~245 (2001)
  12. Bellack AS, "Evaluation of social problem solving in schizophrenia", J Abnorm Psychol, 103, pp.371~378 (1994)
  13. Harvey PD, "Latest developments in the matrics process", Psychiatry(Edgmont), 7, pp.49~52 (2010)
  14. Mausbach BT, "Relationship between functional capacity and community responsibility in patients with schizophrenia : differences between independent and assisted living settings", Community Ment Health J, 44, pp.385~391 (2008)
  15. Twamley EW, "Generalized cognitive impairments, ability to perform everyday tasks, and level of independence in community living situations of older patients with psychosis", Am J Psychiatry, 159, pp.2013~2020 (2002)
  16. Gonzalez JM, "A qualitative assessment of cross-cultural adaptation of intermediate measures for schizophrenia in multisite international studies", Psychiatry Res, 206, pp.166~172 (2013)
  17. Velligan DI, "The cultural adaptability of intermediate measures of functional outcome in schizophrenia", Schizophr Bull, 38, pp.630~641 (2012)
  18. Gardner DM, "International consensus study of antipsychotic dosing", Am J Psychiatry, 167, pp.686~693 (2010)
  19. Rey MJ, "Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics", Int Clin Psychopharmacol, 4, pp.95~104 (1989)
  20. Bonett DG, "Sample size requirements for estimating pearson, kendall and spearman correlations", Psychometrika, 65, pp.23~28 (2000)
  21. Kay SR, "The positive and negative syndrome scale(PANSS)for schizophrenia", Schizophr Bull, 13, pp.261~276 (1987)
  22. Haro JM, "The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia", Acta Psychiatr Scand Suppl, (416), pp.16~23 (2003)
  23. Goldman HH, "Revising axis V for DSM-IV : a review of measures of social functioning", Am J Psychiatry, 149, pp.1148~1156 (1992)
  24. Martin CR, "Factor structure of the Schizophrenia Quality of Life Scale Revision 4(SQLS-R4)", Psychol Health Med, 12, pp.126~134 (2007)
  25. 이중서, "한국판 양성 및 음성증후군 척도(Positive and Negative Syndrome Scale)의 신뢰도와 타당도", 신경정신의학, 40(6), pp.1090~1105 (2001), 대한신경정신의학회
  26. 김진훈, "한국어판 정신분열병 삶의 질 척도의 개발과 PANSS와의 관련성", 신경정신의학, 45(5), pp.401~410 (2006), 대한신경정신의학회
  27. Keefe RS, "The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity", Am J Psychiatry, 163, pp.426~532 (2006)
  28. Allen DN, "Utility of WAIS-R short forms in schizophrenia", Schizophr Res, 26, pp.163~172 (1997)
  29. Berg EA, "Wisconsin Card Sorting Test" (1993), Psychological Assessment Resources
  30. Liddle PF, "Schizophrenic syndromes, cognitive performance and neurological dysfunction", Psychol Med, 17, pp.49~57 (1987)
  31. Addington J, "Cognitive functioning and positive and negative symptoms in schizophrenia", Schizophr Res, 5, pp.123~134 (1991)
  32. Üçok A, "Employment and its relationship with functionality and quality of life in patients with schizophrenia : EGOFORS Study", Eur Psychiatry, 27, pp.422~425 (2012)
  33. Ritsner MS, "Predicting quality of life impairment in chronic schizophrenia from cognitive variables", Qual Life Res, 16, pp.929~937 (2007)
  34. Erlenmeyer-Kimling L, "Attention, memory, and motor skills as childhood predictors of schizophreniarelated psychoses: the New York High-Risk Project", Am J Psychiatry, 157, pp.1416~1422 (2000)
  35. Fujii DE, "Neurocognition and longterm prediction of quality of life in outpatients with severe and persistent mental illness", Schizophr Res, 69, pp.67~73 (2004)
  36. 김성진, "The Relationship between Language Ability and Cognitive Function in Patients with Schizophrenia", Clinical Psychopharmacology and Neuroscience, 13(3), pp.288~295 (2015), 대한정신약물학회
  37. Keefe RS, "Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale", Eur Neuropsychopharmacol, 25, pp.176~184 (2015)

관련 논문AI추천

조현병 장애 등급 평가와 한국판 University of California San Diego 실행에 기초한 기술평가 척도의 유용성강제욱, 김성진, 김유나, 문정준, 박성용, 이윤호, 이충열, 전동욱, 정도운대한생물치료정신의학회 · 생물치료정신의학2018 · 제24권 제2호조현병 환자의 인지기능 및 심리사회적 요인과 직업재활과의 연관성강제욱, 공보금, 김성진, 김현정, 문정준, 서영수, 전동욱, 정도운, 정성수, 하태민대한생물치료정신의학회 · 생물치료정신의학2014 · 제20권 제2호Development of the Instrumental Activities of Daily Living Scale-Ability and Actual Performance: A New Measure for People With SchizophreniaEn-Chi Chiu, Shu-Chun Lee대한신경정신의학회 · PSYCHIATRY INVESTIGATION2026 · 제23권 제1호Validation of the Chinese Version of the Schizophrenia Cognition Rating ScaleChi-Fa Hung, Chih-Ken Chen, Kuan-Wei Huang, Liang-Jen Wang, Pao-Yen Lin, Sheng-Yu Lee, Yu-Chi Huang, Yu Lee대한신경정신의학회 · PSYCHIATRY INVESTIGATION2022 · 제19권 제7호The Relationship between Language Ability and Cognitive Function in Patients with Schizophrenia강제욱, 공보금, 김성진, 문정준, 심주철, 전동욱, 정도운, Beom-Joo Seo, Sung-Soo Jung대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2015 · 제13권 제3호일상생활 수행능력 평가도구의 유효성 분석 연구김가영, 노은정, 이원혜, 임선진, 주채린, 한주현대한노인정신의학회 · 노인정신의학2023 · 제27권 제2호

이 간행물의 다른 논문 (14건)